IGF OT IGF Fluorescent Nanodiamonds for In Vitro and In Vivo Biological Imaging SBIR Topic Phase II

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

• SBIR TOPIC: DEVELOPMENT OF DEVICES, DIAGNOSTIC TECHNOLOGIES, OR DIGITAL HEALTH TOOLS FOR TREATMENT, DETECTION, AND DIAGNOSIS OF PEDIATRIC CANCERS AND/OR RARE CANCERSPHASE I CONCEPT TITLE: EVALUATING
• EO 14042SBIR TOPIC 425 PHASE I:POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML)
• Development of NV-Biosensor platform for quantum-based single molecule detection and its use to detect microRNAs and cortisol as human performance-based biomarkers.
• TOPIC 396 - IMAGING FOR CANCER IMMUNOTHERAPIES-MOONSHOT
• Enzymatic attachment of proteins to fluorescent nanodiamond surfaces.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

• DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY
• Head Up CPR and Aortic Occlusion to Improve Survival after Refractory Cardiac Arrest
• Free-Breathing Dynamic Cardiopulmonary Function Imaging System to use with Xenon MRI
• The Next Wave of Asthma Therapeutics
• Bearingless flux reversal motor for neonatal and pediatric extracorporeal life support applications

Research funding history

9 SBIR/STTR records share this UEI (2005–2025). Reported award amounts total $5,431,502. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards